MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-196.04M
↓ 163% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-74.61M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-196.04M | -67.4% |
| 2024 | $-117.11M | -171.9% |
| 2023 | $-43.06M | +23.0% |
| 2022 | $-55.91M | -58.7% |
| 2021 | $-35.23M | -11023.1% |
| 2020 | $-316692.00 | - |